Related Experiment Video
Updated: Jul 24, 2025

10:12
Enrichment of Mammalian Tissues and Xenopus Oocytes with Cholesterol
Published on: March 25, 2020
6.1K
Cholesterol's Function and Origin in the Alzheimer's Disease Brain
1Department of Molecular Medicine and Department of Neuroscience, UF Scripps, Jupiter, FL, USA.
Journal of Alzheimer'S Disease : JAD
|July 2, 2023
Summary
New research suggests circulating cholesterol entering the brain may cause Alzheimer's disease (AD). This challenges previous beliefs about brain cholesterol and AD, opening new avenues for understanding this neurodegenerative disorder.
Area of Science:
- Neuroscience
- Biochemistry
- Lipid Metabolism
Background:
- Alzheimer's disease (AD) is a neurodegenerative disorder linked to neuroinflammation and altered brain lipids.
- Cholesterol is a critical component of inflammatory lipids, but its specific role in sporadic AD remains unclear.
- A prevailing belief is that brain cholesterol is largely independent of circulating blood cholesterol.
Purpose of the Study:
- To explore the role of cholesterol in the onset of sporadic Alzheimer's disease.
- To investigate the hypothesis that circulating cholesterol permeating into the brain is a critical causal factor in AD.
- To challenge existing paradigms regarding cholesterol homeostasis in the brain concerning AD pathogenesis.
Main Methods:
- This study is theoretical, proposing a new hypothesis based on existing literature.
- It involves critical analysis of current understanding of lipid metabolism and neuroinflammation in AD.
- Future research directions are suggested based on the proposed theory.
Main Results:
- The study posits that the influx of circulating cholesterol into the brain is a key event in the development of AD.
- It suggests that the separation of brain and blood cholesterol pools may be less absolute than previously assumed in the context of AD.
- This challenges the traditional view and offers a new perspective on AD etiology.
Conclusions:
- The permeation of circulating cholesterol into the brain is proposed as a critical causal factor for Alzheimer's disease onset.
- This hypothesis necessitates a re-evaluation of cholesterol's role in AD pathogenesis.
- Further research is warranted to validate this theory and explore its therapeutic implications.
Related Concept Videos
Alzheimer's Disease: Overview
527
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
527
Alzheimer's Disease: Treatment
220
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
220
Role of Neurotransmitters in Memory
666
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
666
Cholesterol: Significance and Regulation
600
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
600
Cholinesterases: Distribution and Function
503
Cholinesterases are a group of serine hydrolase enzymes that play a crucial role in the breakdown of choline esters. The two primary types of cholinesterases are acetylcholinesterases (AChEs) and butyrylcholinesterase (BuChEs), which differ in their distribution, function, and substrate specificity. AChEs, also known as true cholinesterases, specifically hydrolyze acetylcholine, while BuChEs, often referred to as pseudocholinesterases, can hydrolyze various choline esters, including...
503
Amyloid Fibrils
9.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.6K

